amphetamine has been researched along with Weight Gain in 18 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we assessed the effects of exercise on food intake and weight gain of these mice as well as their sensitivity to the stimulant effects of amphetamine." | 3.80 | Differential sensitivity of Pak5, Pak6, and Pak5/Pak6 double-knockout mice to the stimulant effects of amphetamine and exercise-induced alterations in body weight. ( Furnari, MA; Jobes, ML; Minden, A; Nekrasova, T; Wagner, GC, 2014) |
| " Furthermore, the presence or absence of maternal weight loss predicted MK-801 and amphetamine stimulated locomotor abnormalities in offspring." | 3.77 | Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors. ( Ahlbrand, R; Bronson, SL; Horn, PS; Kern, JR; Richtand, NM, 2011) |
| " Yet, analysis of the body weight gain and volumetric determinations of brain areas have not been performed by comparing the effects of neonatal exposure to cocaine and amphetamine." | 3.68 | Body weight gain and hippocampal volumes of rats exposed neonatally to psychostimulants. ( Silva, MC; Tavares, MA, 1993) |
| " In addition, the side-effect profile was established by measuring catalepsy, antipsychotic-induced weight gain, plasma levels of prolactin, and anxiogenic potential." | 1.37 | AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents. ( Arad, M; Barak, S; Black, MD; Borowsky, B; Cohen, C; De Levie, A; Featherstone, RE; Giardino, O; Griebel, G; Pichat, P; Rogacki, N; Senyah, Y; Stemmelin, J; Stevens, RJ; Varty, GB; Weiner, I, 2011) |
| "Weight gain is one side effect of many antipsychotic drugs (APDs)." | 1.31 | Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. ( Bubser, M; Deutch, AY; Fadel, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Potrebić, MS | 1 |
| Pavković, ŽZ | 1 |
| Srbovan, MM | 1 |
| Dmura, GM | 1 |
| Pešić, VT | 1 |
| Furnari, MA | 1 |
| Jobes, ML | 1 |
| Nekrasova, T | 1 |
| Minden, A | 1 |
| Wagner, GC | 1 |
| Duncan, JR | 1 |
| Gibbs, SJ | 1 |
| Lawrence, AJ | 1 |
| Orsini, CA | 1 |
| Ginton, G | 1 |
| Shimp, KG | 1 |
| Avena, NM | 1 |
| Gold, MS | 1 |
| Setlow, B | 1 |
| Der-Avakian, A | 1 |
| Markou, A | 1 |
| Black, MD | 1 |
| Stevens, RJ | 1 |
| Rogacki, N | 1 |
| Featherstone, RE | 1 |
| Senyah, Y | 1 |
| Giardino, O | 1 |
| Borowsky, B | 1 |
| Stemmelin, J | 1 |
| Cohen, C | 1 |
| Pichat, P | 1 |
| Arad, M | 1 |
| Barak, S | 1 |
| De Levie, A | 1 |
| Weiner, I | 1 |
| Griebel, G | 1 |
| Varty, GB | 1 |
| Bronson, SL | 1 |
| Ahlbrand, R | 1 |
| Horn, PS | 1 |
| Kern, JR | 1 |
| Richtand, NM | 2 |
| Vorhees, CV | 1 |
| Graham, DL | 1 |
| Braun, AA | 1 |
| Schaefer, TL | 1 |
| Skelton, MR | 1 |
| Williams, MT | 1 |
| Fadel, J | 1 |
| Bubser, M | 1 |
| Deutch, AY | 1 |
| CHAPMAN, JD | 1 |
| HANSON, IR | 1 |
| BAKER, RL | 1 |
| GALLAHER, JP | 1 |
| BRESLOW, S | 1 |
| BELAFSKY, HA | 1 |
| SHANGOLD, JE | 1 |
| HIRSCH, LM | 1 |
| STAHL, MB | 1 |
| de Jong, JG | 1 |
| Wasilewski, M | 1 |
| van der Vegt, BJ | 1 |
| Buwalda, B | 1 |
| Koolhaas, JM | 1 |
| McCormick, CM | 1 |
| Robarts, D | 1 |
| Kopeikina, K | 1 |
| Kelsey, JE | 1 |
| Kanarek, RB | 1 |
| Marks-Kaufman, R | 1 |
| D'Anci, KE | 1 |
| Przypek, J | 1 |
| Tavares, MA | 2 |
| Silva, MC | 2 |
| Silva-Araújo, A | 1 |
| Xavier, MR | 1 |
| Ali, SF | 1 |
| Parada, MA | 1 |
| Puig de Parada, M | 1 |
| Hernandez, L | 1 |
| Murzi, E | 1 |
18 other studies available for amphetamine and Weight Gain
| Article | Year |
|---|---|
Changes in the Behavior and Body Weight of Mature, Adult Male Wistar Han Rats after Reduced Social Grouping and Social Isolation.
Topics: Amphetamine; Animals; Behavior, Animal; Body Weight; Exploratory Behavior; Male; Rats; Rats, Wistar; | 2022 |
Differential sensitivity of Pak5, Pak6, and Pak5/Pak6 double-knockout mice to the stimulant effects of amphetamine and exercise-induced alterations in body weight.
Topics: Amphetamine; Animals; Brain Chemistry; Drinking; Eating; Energy Intake; Estrogen Receptor alpha; Fem | 2014 |
Chronic intermittent toluene inhalation in adolescent rats alters behavioural responses to amphetamine and MK801.
Topics: Aging; Amphetamine; Animals; Central Nervous System Stimulants; Dizocilpine Maleate; Excitatory Amin | 2014 |
Food consumption and weight gain after cessation of chronic amphetamine administration.
Topics: Amphetamine; Animals; Behavior, Animal; Diet; Eating; Energy Intake; Feeding Behavior; Food Preferen | 2014 |
Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.
Topics: Amphetamine; Animals; Body Weight; Central Nervous System Stimulants; Conditioning, Operant; Depress | 2010 |
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.
Topics: Acoustic Stimulation; Amphetamine; Animals; Antipsychotic Agents; Anxiety; Behavior, Animal; Catalep | 2011 |
Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors.
Topics: Age Factors; Amphetamine; Analysis of Variance; Animals; Animals, Newborn; Antiviral Agents; Behavio | 2011 |
Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC.
Topics: Amphetamine; Animals; Dizocilpine Maleate; Dopamine Agents; Excitatory Amino Acid Antagonists; Femal | 2012 |
Differential activation of orexin neurons by antipsychotic drugs associated with weight gain.
Topics: Amphetamine; Animals; Antipsychotic Agents; Body Weight; Carrier Proteins; Cell Count; Central Nervo | 2002 |
Control of weight gain in pregnancy, utilizing methamphetamine.
Topics: Amphetamine; Amphetamines; Female; Humans; Methamphetamine; Obesity; Pregnancy; Pregnancy Complicati | 1961 |
PROBLEM WEIGHT GAIN IN "WANTED" VERSUS "UNWANTED" PREGNANCIES.
Topics: Amphetamine; Emotions; Female; Humans; Infant, Newborn; Obesity; Pregnancy; Pregnancy, Unwanted; Pro | 1963 |
Control of weight gain in pregnancy: double blind study of a dieting aid.
Topics: Amphetamine; Amphetamines; Diet, Reducing; Double-Blind Method; Female; Humans; Meprobamate; Pregnan | 1963 |
A single social defeat induces short-lasting behavioral sensitization to amphetamine.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Competitive Behavior; Dos | 2005 |
Long-lasting, sex- and age-specific effects of social stressors on corticosterone responses to restraint and on locomotor responses to psychostimulants in rats.
Topics: Age Factors; Amphetamine; Animals; Central Nervous System Stimulants; Corticosterone; Female; Habitu | 2005 |
Exercise attenuates oral intake of amphetamine in rats.
Topics: Administration, Oral; Amphetamine; Animals; Diet; Drinking; Eating; Male; Motor Activity; Physical E | 1995 |
Body weight gain and hippocampal volumes of rats exposed neonatally to psychostimulants.
Topics: Amphetamine; Analysis of Variance; Animals; Animals, Newborn; Body Weight; Cocaine; Hippocampus; Mal | 1993 |
Effects of prenatal exposure to amphetamine in the medial prefrontal cortex of the rat.
Topics: Amphetamine; Animals; Body Weight; Brain Chemistry; Central Nervous System Stimulants; Dopamine; Fem | 1996 |
Ventromedial hypothalamus vs. lateral hypothalamic D2 satiety receptors in the body weight increase induced by systemic sulpiride.
Topics: Amphetamine; Animals; Eating; Female; Hypothalamic Area, Lateral; Injections; Injections, Intraperit | 1991 |